Senti Bio appoints Bryan Baum to Board of Directors

Senti Biosciences, Inc.

Bryan Baum, co-founder and managing partner of K5 Global, appointed to board effective July 18, 2025.
Baum received initial option award for 43,900 shares vesting monthly over three years; annual cash retainer $35,000.
Board size increased from seven to eight members; Baum fills new seat as Class II director until 2027 annual meeting.
Baum's portfolio includes SpaceX, xAI, Anduril, OpenAI; previously sold companies Blue Vision Labs, Parrot, Operam.

item 5.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.